Natural killer cells in herpesvirus infections.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28781750)

Published in F1000Res on July 26, 2017

Authors

Christian Münz1, Obinna Chijioke1,2

Author Affiliations

1: Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Winterthurerstrasse, Zurich, Switzerland.
2: Institute of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse, Zurich, Switzerland.

Articles cited by this

In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today (1990) 10.84

Adaptive immune features of natural killer cells. Nature (2009) 8.46

Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science (2002) 7.70

"Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol (1975) 7.61

Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med (1989) 7.52

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol (2001) 7.07

Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer (1975) 5.91

Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity (2007) 5.50

Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A (2002) 5.17

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med (1978) 4.86

Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol (2010) 4.34

Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood (2011) 4.21

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood (2011) 3.66

Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood (2010) 3.58

Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A (2011) 3.53

Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med (2013) 3.41

Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 3.38

Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood (2004) 3.36

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science (2000) 3.20

Infectious mononucleosis. N Engl J Med (2010) 3.10

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med (2010) 2.89

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A (2005) 2.80

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology (2009) 2.66

Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A (2004) 2.66

The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol (2004) 2.64

Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med (1998) 2.60

Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis (2006) 2.49

Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood (2005) 2.40

Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis (2012) 2.33

NK cell compartments and their activation by dendritic cells. J Immunol (2004) 2.22

Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med (1994) 2.17

Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science (2013) 2.00

Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog (2011) 1.81

CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur J Immunol (2011) 1.81

Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity (2015) 1.71

Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity (2015) 1.68

Natural killer cells: walking three paths down memory lane. Trends Immunol (2013) 1.57

Control of murine gammaherpesvirus infection is independent of NK cells. Eur J Immunol (2005) 1.57

Activated lymphocytes during acute Epstein-Barr virus infection. J Immunol (1987) 1.42

Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J Clin Invest (2012) 1.35

In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology (2007) 1.35

The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing. J Virol (2006) 1.35

Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRγ deficiency. J Immunol (2013) 1.35

Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood (2010) 1.32

The immune response to primary EBV infection: a role for natural killer cells. Br J Haematol (2005) 1.30

In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice. J Immunol (1984) 1.29

Cutting edge: a NK complex-linked locus governs acute versus latent herpes simplex virus infection of neurons. J Immunol (2001) 1.26

An inquiry into the molecular basis of HSV latency and reactivation. Annu Rev Microbiol (2013) 1.21

The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. J Immunol (1986) 1.20

Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur J Immunol (2010) 1.17

IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. J Clin Invest (2014) 1.17

Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood. J Immunol (2014) 1.12

Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection. Cell Rep (2013) 1.12

Immunosurveillance and immunotherapy of tumors by innate immune cells. Curr Opin Immunol (2015) 1.10

Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus. J Immunol (2014) 1.08

IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function. J Immunol (2009) 1.07

Role for early-differentiated natural killer cells in infectious mononucleosis. Blood (2014) 0.99

Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans. Cell Rep (2016) 0.98

Immune Adaptation to Environmental Influence: The Case of NK Cells and HCMV. Trends Immunol (2016) 0.97

Characterization of natural killer cell phenotype and function during recurrent human HSV-2 infection. PLoS One (2011) 0.94

Hantavirus-infection confers resistance to cytotoxic lymphocyte-mediated apoptosis. PLoS Pathog (2013) 0.91

Antibody-mediated response of NKG2Cbright NK cells against human cytomegalovirus. J Immunol (2015) 0.90

Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice. PLoS Pathog (2014) 0.88

Interactions of human myeloid cells with natural killer cell subsets in vitro and in vivo. J Biomed Biotechnol (2011) 0.87

The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events. PLoS Pathog (2015) 0.86

Newtonian cell interactions shape natural killer cell education. Immunol Rev (2015) 0.81

New insights on the natural killer cell repertoire from a thorough analysis of cord blood cells. J Leukoc Biol (2016) 0.81

Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children. PLoS Pathog (2015) 0.81

Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets. J Immunol (2016) 0.79

Class I HLA haplotypes form two schools that educate NK cells in different ways. Sci Immunol (2016) 0.79

Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest (2016) 0.78

Purification and HPLC-MS analysis of a naturally processed HCMV-derived peptide isolated from the HEK-293T/HLA-E+/Ul40+ cell transfectants and presented at the cell surface in the context of HLA-E. J Immunol Methods (2007) 0.78

Tracking the fate of antigen-specific versus cytokine-activated natural killer cells after cytomegalovirus infection. J Exp Med (2016) 0.78

Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I. Immunity (2016) 0.76

Adaptive NKG2C+ NK Cell Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients. J Immunol (2016) 0.75